Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

INTERCEPT-AMD

In this page

Clinical Trial

NCT05698316 Recruiting, Active
INTERCEPT-AMD

A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression: (INTERCEPT-AMD)

Observational
Observational

Disease

Disease type

Other

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

04/05/2023

Closing date

30/04/2025

Inclusion criteria :

More

Exclusion criteria :

More

Funding

private

Members involved

Others investigators

Pr Frank Holz

Representative

Germany

See more

Dr Philipp Herrmann

Substitute

Germany

CPMS & Digital Medecine (TWG10), Genetic Diagnostics (TWG6), Research (TWG8), Retinal Rare Eye Diseases (WG1)
See more

Pr Daniel Böhringer

Representative

Germany

Anterior Segment Rare Eye Diseases (WG4)
Working Group Leader
See more

PD Dr Markus Preising

Representative

Germany

Pediatric Ophthalmology Rare Diseases (WG3), Research (TWG8), Retinal Rare Eye Diseases (WG1)
See more

Pr Carel HOYNG

Representative

Netherlands

Genetic Diagnostics (TWG6), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
See more

ERN EYE member investigating site

HCP : Principal investigators

Universitätsklinikum Gießen und Marburg GmbH, Gießen, Germany

Adress

Klinik und Poliklinik für Augenheilkunde Friedrichstr. 18

35392 Gießen

Germany